Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in City of Lancaster: The Definitive Guide for Women, Families, and Survivors
We understand the resilience of women in City of Lancaster who have navigated the life-altering challenges of breast cancer, prophylactic mastectomy, or complex revision surgery. You made decisions for your health and your future, often choosing reconstruction or augmentation procedures in the prominent medical hubs serving Dallas County, believing that the materials implanted in your body were proven safe for their intended use. However, for many women in City of Lancaster, that trust has been betrayed by medical device manufacturers who marketed surgical mesh, acellular dermal matrix (ADM), and bioabsorbable scaffolds for breast surgery without ever obtaining specific FDA clearance for those procedures.
As serious injury and product liability attorneys, we recognize that you are likely reading this while managing physical pain, emotional exhaustion, or the devastating reality of a reconstruction failure. At The Manginello Law Firm, PLLC, operating under the Attorney911 brand, we advocate for women in City of Lancaster who have been harmed by these defective devices. Led by Managing Partner Ralph Manginello, who has been licensed by the State Bar of Texas since 1998, we bring twenty-seven years of continuous legal experience to the fight against institutional negligence. We are not just generalists; we are trial lawyers with the substantive command of federal litigation and medical device pathology required to take on the world’s largest manufacturers.
Whether your surgery took place at a major academic medical center in the nearby Dallas Medical District or an ambulatory surgical center serving the City of Lancaster area, you are entitled to know if the complications you are facing—such as skin-flap necrosis, persistent seroma, red breast syndrome, or the rare cancers BIA-ALCL and BIA-SCC—were caused by a device that was never determined by the FDA to be safe or effective for breast applications. We represent families in City of Lancaster with the same intensity we bring to our current high-profile litigation, such as Bermudez v. Pi Kappa Phi, where we are seeking $10,000,000 against thirteen defendants to end institutional hazing. We apply that same aggressive, detailed-oriented strategy to hold device manufacturers accountable for the materials they put into the bodies of women in City of Lancaster.
Understanding the Devices: ADM, Scaffolds, and Mesh in City of Lancaster Procedures
To protect your rights in City of Lancaster, it is essential to first understand exactly what was placed in your body. In both reconstructive and cosmetic surgeries around City of Lancaster, surgeons often use materials to reinforce the “lower pole” of the breast or to create an “internal bra” to support an implant. These products fall into three primary categories, and while they are common in City of Lancaster operating rooms, their regulatory history is fraught with shortcuts and missing clinical data.
Acellular Dermal Matrix (ADM) is a biologic material, often derived from human cadaver skin or porcine (pig) tissue. Brands like AlloDerm (made by LifeCell/Allergan/AbbVie), Strattice, FlexHD, and AlloMax have been used in thousands of City of Lancaster reconstructions. While these materials are cleared for general soft-tissue reinforcement, the FDA has explicitly stated they have not been cleared for breast-specific use.
Bioabsorbable Scaffolds are synthetic materials designed to be resorbed by the body over time. The most controversial of these products used in City of Lancaster is GalaFLEX, manufactured by Galatea Surgical and Becton Dickinson (BD), composed of poly-4-hydroxybutyrate (P4HB). Other synthetic scaffolds include Phasix and DuraSorb. These “internal bra” products were marketed to City of Lancaster surgeons as a way to provide long-term support that eventually disappears, yet many women in City of Lancaster have reported that these scaffolds fail to resorb on the manufacturer’s timeline, leading to palpable mesh edges, chronic inflammation, and deformity.
Finally, synthetic surgical mesh, often polypropylene-based, was sometimes used off-label in City of Lancaster breast procedures. These materials were never intended for the delicate tissue of the breast and have been a primary focus of global mesh litigation after causing catastrophic infections and tissue erosion. When these products fail for a patient in City of Lancaster, the medical and financial consequences are severe. We are here to help you navigate the aftermath. If you have questions about the specific brand of mesh or ADM used in your surgery, contact us at 1-888-ATTY-911 for a confidential, no-obligation consultation.
The FDA Regulatory Failure: 510(k) “Substantial Equivalence” and City of Lancaster Patients
Many of our clients in City of Lancaster are shocked to learn that the mesh or ADM used in their breast surgery was never actually “approved” by the FDA for that purpose. Instead, most of these products entered the market through the 510(k) clearance pathway. Under 21 USC §360c and 21 CFR Part 807 Subpart E, a manufacturer only needs to show that their device is “substantially equivalent” to a “predicate device” already on the market.
This process, known as the 510(k) pathway, does not require the evaluative clinical trials that a Premarket Approval (PMA) would require. As we explain to women in City of Lancaster, this has led to “predicate creep,” where a device like GalaFLEX is cleared by claiming it is similar to a surgical suture—a comparison that lacks clinical logic for the complex environment of the breast.
The FDA’s own words confirm the danger. In a landmark November 9, 2023 letter to health care providers titled “Labeling Updates for BD Mesh Products,” the FDA stated: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.” This letter specifically named products frequently used in City of Lancaster, including GalaFLEX and Phasix. For a woman in City of Lancaster who was told her reconstruction materials were the “gold standard,” this document is a powerful piece of evidence that the manufacturer’s marketing did not match the regulatory reality.
Because these devices are 510(k) cleared, they do not benefit from the same federal preemption shields that protected PMA-approved devices in cases like Riegel v. Medtronic. Under the precedent of Medtronic v. Lohr, 518 U.S. 470 (1996), state-law product liability claims for 510(k) devices are not preempted. This means we can aggressively pursue design defect, manufacturing defect, and failure to warn claims on behalf of City of Lancaster residents in the United States District Court for the Northern District of Texas, Dallas Division.
Deep Pathology: The Real Complications Facing Women in City of Lancaster
When we talk with women in City of Lancaster about their injuries, we don’t use generic terms. We use the technical language that the medical literature demands, because that is how we build a case that survives defense scrutiny. If you are in City of Lancaster and experiencing redness, fluid buildup, or a loss of your reconstruction, you may be facing one of several documented device-related pathologies.
Red Breast Syndrome (RBS) and Endotoxin Science
Many patients in City of Lancaster who received ADM report persistent, sterile redness of the breast. This is often “Red Breast Syndrome,” a non-infectious inflammatory response. Peer-reviewed research, including studies by Nguyen et al. (2019), suggests RBS is caused by bacterial endotoxins (lipopolysaccharides) retained on the ADM through the sterilization process. While the bacteria are dead, the endotoxin remains biologically active. We have seen levels as high as 320 eu/graft in RBS patients. For a woman in City of Lancaster, this means her body is reacting to a “dirty” biologic material that should have been more rigorously screened by the manufacturer.
BIA-ALCL: The Textured Implant Cancer
For City of Lancaster residents who received textured breast implants—most notably the Allergan BIOCELL line—there is a documented risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). This is a CD30-positive, ALK-negative T-cell lymphoma classified as a distinct cancer by the World Health Organization since 2016. It typically presents as a periprosthetic seroma (fluid collection) 7 to 10 years after implantation. The FDA requested a global recall of BIOCELL textured products in July 2019 because they were linked to a nearly six-fold higher risk of this cancer. We represent City of Lancaster patients in the consolidated MDL 2921 (District of New Jersey), where the bellwether trial is currently set for October 19, 2026.
BIA-SCC: Emerging Squamous Cell Carcinoma
An even rarer but equally serious malignancy is Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC). In March 2023, the FDA issued a safety communication reporting 19 cases in the literature and three deaths. BIA-SCC develops in the capsule surrounding the implant and can manifest decades after surgery. If you were a patient in City of Lancaster who received an implant long ago and are now experiencing changes in your breast capsule, immediate biopsy and legal consultation are critical.
Scaffold Resorption Failure and Chronic Pain
Bioabsorbable scaffolds like GalaFLEX are supposed to resorb as the body produces its own collagen. However, we have seen cases in City of Lancaster where these scaffolds persist long past the 18-to-24-month window, creating a chronic foreign body reaction, “bottoming out,” or sharp, neuropathic pain. If the scaffold in your body has failed to resorb, it is not working as advertised, and you may have a claim for design defect.
Why Experience Matters: Attorney911’s Commitment to City of Lancaster
The choice of an attorney in City of Lancaster makes a material difference in the outcome of a medical device case. Many generalist personal injury firms in Dallas County might treat these cases like a car accident. We treat them as the complex, high-stakes institutional liability matters they are. Ralph Manginello’s twenty-seven years of practice and admission to the United States District Court for the Southern District of Texas (and our work across the Northern District) give our firm the federal-court fluency needed to navigate JDML consolidations and MDL proceedings.
Furthermore, we recognize the diverse demographic makeup of City of Lancaster. Access to justice should never be gated by language. Associate Attorney Lupe Peña, a third-generation Texan, conducts full client consultations in fluent Spanish without the need for outside interpreters. This direct attorney-client communication is a significant advantage for Spanish-dominant families in City of Lancaster who were never told—in their own language—that the devices being used in their bodies were experimental. Hablamos español, and we are ready to listen to your story.
Our firm’s reputation is validated by the people we serve. We maintain a 4.9 out of 5.0 rating across hundreds of Birdeye reviews, and Ralph Manginello holds an Avvo “Excellent” rating of 8.2 with 100% five-star client reviews. We are members of the Pro Bono College of the State Bar of Texas, reflecting a service ethic that goes beyond the billable hour. When you call 1-888-ATTY-911, you aren’t just getting an intake clerk; you are reaching a firm that current news outlets like KPRC 2 and ABC13 have featured for our aggressive prosecution of multi-million dollar institutional cases.
The Whistleblower’s Evidence: Dr. Hooman Noorchashm and Becton Dickinson
One of the most compelling pieces of evidence available to patients in City of Lancaster comes from within the industry itself. Dr. Hooman Noorchashm, a cardiothoracic surgeon and former Medical Director at Becton Dickinson (BD), became a whistleblower after raising safety concerns about the marketing of GalaFLEX mesh for breast reconstruction.
Dr. Noorchashm has alleged that BD withheld data concerning breast cancer recurrences in its clinical trials and failed to properly report adverse events to the FDA’s MAUDE database. His public advocacy includes a formal citizen petition to the FDA, objecting to the off-label promotion of mesh products to City of Lancaster surgeons and hospital systems. For our clients in City of Lancaster, the Noorchashm record provides a “smoking gun” that manufacturers were on notice about the risks of their products but chose profit and market share over patient safety. We incorporate these whistleblower facts into our discovery process to pierce the manufacturer’s defense that “they didn’t know.”
Governing Law: Statutes and Damages in City of Lancaster, Texas
If you are a resident of City of Lancaster, your case is governed by the Texas Civil Practice and Remedies Code. Understanding these statutes is vital for preserving your right to recovery.
The Statute of Limitations: In Texas, you generally have two years from the date of injury to file a product liability lawsuit. However, the “Discovery Rule” is often critical in City of Lancaster device cases. Because BIA-ALCL or scaffold failure may take years to manifest, the clock may not start until you discovered—or reasonably should have discovered—the link between your injury and the device. With the FDA’s labeling update in November 2023, many women in City of Lancaster are only now entering their discovery window.
Statute of Repose: Texas has a 15-year statute of repose for most product liability actions, meaning you cannot sue more than 15 years after the first sale of the product, regardless of when the injury occurred.
Damage Caps: Under Texas Civil Practice and Remedies Code Chapter 74, non-economic damages (pain and suffering, emotional distress, disfigurement) are generally capped at $250,000 against a single healthcare institution and $500,000 overall in medical liability cases. However, these caps do not apply to the product liability claims against the device manufacturers like Allergan or Becton Dickinson. This is why our strategy focuses on the manufacturers, where we can seek full, uncapped compensation for the economic and personal devastation you have suffered in City of Lancaster.
The Breast Cancer Disparity: A Concern for City of Lancaster Families
We are keenly aware of the health disparities affecting Black women in City of Lancaster and the surrounding Dallas County area. The medical literature shows that while Black women have a slightly lower incidence of breast cancer than white women, they have a 38% higher mortality rate. Furthermore, triple-negative breast cancer—an aggressive subtype—is twice as common in African American women.
When women in City of Lancaster undergo mastectomy and reconstruction, they deserve the highest standard of care and safe materials. Yet studies suggest that Black women have historically been offered immediate reconstruction at lower rates or may have been subject to different informed-consent processes. If you are a woman of color in City of Lancaster who was injured by a defective device, we are committed to providing the aggressive, culturally sensitive advocacy you need to ensure your voice is heard in the legal system. Our bilingual capacity and our rootedness in the community allow us to serve the entire population of City of Lancaster.
Frequently Asked Questions for City of Lancaster Residents
Is surgical mesh approved by the FDA for breast surgery?
No. The FDA confirmed in 2023 that no surgical mesh products have been cleared or approved for use in breast augmentation or reconstruction. They are used “off-label” in City of Lancaster and throughout the country.
What if my surgeon told me the ADM was safe?
Surgeons in City of Lancaster are often the recipients of biased information from manufacturer sales representatives. If the manufacturer failed to warn your surgeon about the high complication rates of products like FlexHD or AlloMax, the manufacturer is liable.
Do I need to have the mesh removed to file a lawsuit?
While having the device explanted can provide physical evidence (pathology slides and the device itself), it is not a requirement to start your legal claim. If you are in pain or have failed reconstruction in City of Lancaster, you should call us at 1-888-ATTY-911 now.
How do I find out which brand of mesh was used?
We can help you secure your operative reports and “device implant stickers” from the hospital where your surgery was performed. This information is legally yours, and we know how to cut through hospital bureaucracy in City of Lancaster to get it.
What does it cost to hire Attorney911?
We operate on a contingency fee basis. This means women in City of Lancaster pay us nothing upfront and no fee unless we win your case. We take all the financial risk because we believe in the merit of these claims.
Evidence Preservation: A Step-by-Step Guide for City of Lancaster Survivors
If you suspect your reconstruction is failing or you have been diagnosed with a device-related complication in City of Lancaster, take these steps immediately to protect your legal rights:
- Request Your Records: Ask for the complete “operative report” and “implant log” from your surgeon’s office or the hospital. Look for the Unique Device Identifier (UDI) and lot numbers.
- Preserve the Device: If you are undergoing revision surgery in City of Lancaster, instruct your surgeon and the hospital’s pathology department to preserve the explanted mesh, scaffold, or ADM. It is your property. Do not let the hospital return it to the manufacturer for “testing.”
- Document Symptoms: Keep a journal of your symptoms—photograph redness (RBS), document fluid drainage, and record your pain levels and the dates of every doctor’s visit.
- Save Financial Records: For patients in City of Lancaster, the “financial toxicity” of these complications is real. Save every bill, pharmacy receipt, and record of lost wages.
- Contact Counsel: Call The Manginello Law Firm at 1-888-ATTY-911. The sooner we are involved, the better we can ensure evidence is preserved and your statute of limitations is protected.
A Path Forward for the Women of City of Lancaster
You went into surgery in City of Lancaster expecting to be made whole. Instead, you were treated as a test subject for devices that were never proven safe for your body. You do not have to carry this burden alone. The Manginello Law Firm, PLLC, is dedicated to helping women in City of Lancaster find justice.
Whether you are a breast cancer survivor, a BRCA carrier who chose prophylactic surgery, or a cosmetic patient who was never warned of the risks, we have the resources, the technical expertise, and the trial experience to fight for you. We are not intimidated by the corporate legal teams of Allergan, Becton Dickinson, or Johnson & Johnson. We are the firm that shuts down dangerous institutions and recovers multi-million dollar settlements for our clients.
If you or a loved one in City of Lancaster has been injured by defective breast mesh, ADM, or a bioabsorbable scaffold, call us today at 1-888-ATTY-911. We offer free, confidential consultations in English and Spanish. Let Managing Partner Ralph Manginello and our entire team start working on your recovery. Your well-being is our primary goal, and together, we can hold these manufacturers accountable for what they have done.
Attorney911 | The Manginello Law Firm, PLLC
1177 West Loop South, Suite 1600, Houston, TX 77027
Serving City of Lancaster and residents throughout Dallas County
1-888-ATTY-911 (1-888-288-9911)
Hablamos Español — Consultas en su idioma.
